Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30–60 μm: Results from a Single-Centre Prospective Phase II Trial
Titel:
Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30–60 μm: Results from a Single-Centre Prospective Phase II Trial
Auteur:
Malagari, K. Moschouris, H. Kiakidis, Th. Harward, S. Kelekis, A. Vrakas, S. Koundouras, D. Filipiadis, D. Glantzounis, G. Emmanouil, E. Chatziioannou, A. Vergadis, V. Elefsiniotis, I. Koskinas, J. Dourakis, S. Kelekis, N.